{"id":"https://openalex.org/W2182938544","doi":"https://doi.org/10.1016/s0022-2275(20)42780-4","title":"Increased alpha 2-adrenergic binding sites and antilipolytic effect in adipocytes from genetically obese rats.","display_name":"Increased alpha 2-adrenergic binding sites and antilipolytic effect in adipocytes from genetically obese rats.","publication_year":1990,"publication_date":"1990-05-01","ids":{"openalex":"https://openalex.org/W2182938544","doi":"https://doi.org/10.1016/s0022-2275(20)42780-4","mag":"2182938544","pmid":"https://pubmed.ncbi.nlm.nih.gov/2166122"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-2275(20)42780-4","doi":"https://doi.org/10.1016/s0022-2275(20)42780-4","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0022-2275(20)42780-4","pdf_url":null,"source":{"id":"https://openalex.org/S11400418","display_name":"Journal of Lipid Research","issn_l":"0022-2275","issn":["0022-2275","1539-7262"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Lipid Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s0022-2275(20)42780-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045005810","display_name":"Christian Carp\u00e9n\u00e9","orcid":"https://orcid.org/0000-0001-7765-6647","observed_orcids":["https://orcid.org/0000-0001-7765-6647"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Carp\u00e9n\u00e9","raw_affiliation_strings":["INSERM U 317, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 317, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056586485","display_name":"Marie\u2010Christine Rebourcet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"MC Rebourcet","raw_affiliation_strings":["INSERM U 317, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 317, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022156713","display_name":"C Guichard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Guichard","raw_affiliation_strings":["INSERM U 317, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 317, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011234349","display_name":"Max Lafontan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Lafontan","raw_affiliation_strings":["INSERM U 317, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 317, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034344687","display_name":"Marcelle M. Lavau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Lavau","raw_affiliation_strings":["INSERM U 317, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 317, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I154526488"],"apc_list":{"value":3430,"currency":"USD","value_usd":3430},"apc_paid":{"value":3430,"currency":"USD","value_usd":3430},"fwci":0.5982,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.59948276,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"31","issue":"5","first_page":"811","last_page":"819"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6948000192642212,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6948000192642212,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11457","display_name":"Adipose Tissue and Metabolism","score":0.15299999713897705,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":0.05510000139474869,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/adipocytes","display_name":"adipocytes","score":0.9779999852180481},{"id":"https://openalex.org/keywords/genetic-obesity","display_name":"genetic obesity","score":0.6980000138282776},{"id":"https://openalex.org/keywords/zucker-rats","display_name":"Zucker rats","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antilipolytic-effect","display_name":"antilipolytic effect","score":0.9399999976158142},{"id":"https://openalex.org/keywords/uk-14-304","display_name":"UK 14,304","score":0.9430000185966492},{"id":"https://openalex.org/keywords/idazoxan","display_name":"idazoxan","score":0.8510000109672546},{"id":"https://openalex.org/keywords/epinephrine","display_name":"epinephrine","score":0.871999979019165},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.9319999814033508},{"id":"https://openalex.org/keywords/imidazoline-binding-sites","display_name":"imidazoline binding sites","score":0.7279999852180481},{"id":"https://openalex.org/keywords/white-adipose-tissue","display_name":"white adipose tissue","score":0.7680000066757202},{"id":"https://openalex.org/keywords/receptor-binding-sites","display_name":"receptor binding sites","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7177479267120361},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6959577202796936},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5478193759918213},{"id":"https://openalex.org/C158453852","wikidata":"https://www.wikidata.org/wiki/Q4684738","display_name":"Adrenergic","level":3,"score":0.5150470733642578},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.463215172290802},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.4253145456314087},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.4210956394672394},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3751404881477356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21098753809928894},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13232311606407166},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068438","descriptor_name":"Brimonidine Tartrate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004146","descriptor_name":"Dioxanes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004837","descriptor_name":"Epinephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008066","descriptor_name":"Lipolysis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019329","descriptor_name":"Idazoxan","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0022-2275(20)42780-4","doi":"https://doi.org/10.1016/s0022-2275(20)42780-4","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0022-2275(20)42780-4","pdf_url":null,"source":{"id":"https://openalex.org/S11400418","display_name":"Journal of Lipid Research","issn_l":"0022-2275","issn":["0022-2275","1539-7262"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Lipid Research","raw_type":"journal-article"},{"id":"pmid:2166122","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2166122","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of lipid research","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:a0e437b74fc048d5b2e4a815d55c4775","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a0e437b74fc048d5b2e4a815d55c4775","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Lipid Research, Vol 31, Iss 5, Pp 811-819 (1990)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/s0022-2275(20)42780-4","doi":"https://doi.org/10.1016/s0022-2275(20)42780-4","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0022-2275(20)42780-4","pdf_url":null,"source":{"id":"https://openalex.org/S11400418","display_name":"Journal of Lipid Research","issn_l":"0022-2275","issn":["0022-2275","1539-7262"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Lipid Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W40697381","https://openalex.org/W270985042","https://openalex.org/W1528479578","https://openalex.org/W1775749144","https://openalex.org/W1890547526","https://openalex.org/W1935384768","https://openalex.org/W1975700536","https://openalex.org/W1976368911","https://openalex.org/W1980385296","https://openalex.org/W1983115426","https://openalex.org/W1990172258","https://openalex.org/W1991335338","https://openalex.org/W1999691892","https://openalex.org/W2000725497","https://openalex.org/W2004809480","https://openalex.org/W2006901747","https://openalex.org/W2012335673","https://openalex.org/W2018690427","https://openalex.org/W2024243304","https://openalex.org/W2032996897","https://openalex.org/W2046919916","https://openalex.org/W2046967854","https://openalex.org/W2059953158","https://openalex.org/W2070023150","https://openalex.org/W2072431227","https://openalex.org/W2091851259","https://openalex.org/W2094119110","https://openalex.org/W2143873575","https://openalex.org/W2184840675","https://openalex.org/W2186289457","https://openalex.org/W2209449255","https://openalex.org/W2269717305","https://openalex.org/W2320010944","https://openalex.org/W2339866758","https://openalex.org/W2410256428"],"related_works":["https://openalex.org/W2080160262","https://openalex.org/W2000725497","https://openalex.org/W2209449255","https://openalex.org/W2037584093","https://openalex.org/W1990172258","https://openalex.org/W2268976052","https://openalex.org/W1983115426","https://openalex.org/W1913868332","https://openalex.org/W1980385296","https://openalex.org/W2106662850"],"abstract_inverted_index":{"We":[0],"have":[1],"recently":[2],"shown":[3],"that":[4,93,144],"functional":[5],"alpha":[6,12,44,118,151,164,182,187,218],"2-adrenergic":[7,219],"receptors,":[8],"assessed":[9],"by":[10,86],"the":[11,34,97,137,168],"2-agonist":[13],"UK":[14,70,102,139],"14304,":[15],"are":[16],"present":[17,35],"in":[18,24,57,74,77,96,110,113,128,191,194,214,236],"rat":[19,41],"white":[20],"fat":[21,42,58],"cells":[22,59],"as":[23],"adipocytes":[25],"of":[26,33,69,126,180,186,234],"humans":[27],"and":[28,46,52,141,176,227,231],"other":[29],"species.":[30],"The":[31,65,116,184,216],"aim":[32],"study":[36],"was":[37,72,84,94,108,189],"to":[38,47],"further":[39],"characterize":[40],"cell":[43],"2-adrenoceptors":[45,152],"examine":[48],"whether":[49],"their":[50],"number":[51,125,185],"biological":[53],"effect":[54,68],"were":[55],"altered":[56],"from":[60,167],"genetically":[61],"obese":[62,75,98,111,129,192],"Zucker":[63],"rats.":[64,99],"maximal":[66],"antilipolytic":[67,91],"14304":[71,103,140],"higher":[73,95,109,124,190],"than":[76,112,193,210],"lean":[78,114,195],"littermates.":[79],"Epinephrine,":[80],"when":[81],"its":[82],"beta-component":[83],"blocked":[85],"propranolol,":[87],"also":[88,121,154],"induced":[89],"an":[90,163],"response":[92],"Similarly,":[100],"3H-labeled":[101,138,160],"binding":[104,156],"on":[105,225],"adipocyte":[106,181,217],"membranes":[107],"animals.":[115,130],"radiolabeled":[117],"2-antagonist":[119,165],"[3H]idazoxan":[120],"recognized":[122],"a":[123,222],"sites":[127,175],"However,":[131],"epinephrine":[132],"only":[133,150],"partially":[134],"competed":[135],"for":[136],"[3H]idazoxan,":[142],"suggesting":[143],"these":[145,174],"imidazolinic":[146],"radioligands":[147],"labeled":[148],"not":[149,172],"but":[153],"nonadrenergic":[155],"sites.":[157],"By":[158],"contrast,":[159],"RX":[161],"821002,":[162],"derived":[166],"idazoxan":[169],"family,":[170],"did":[171],"recognize":[173],"allowed":[177],"accurate":[178],"quantification":[179],"2-adrenoceptors.":[183],"2-sites":[188],"littermates":[196],"(Bmax":[197],"=":[198],"64":[199],"+/-":[200,204],"5":[201,230],"vs":[202],"39":[203],"2":[205],"fmol/mg":[206],"protein,":[207],"P":[208],"less":[209],"0.01)":[211],"without":[212],"change":[213],"affinity.":[215],"responsiveness":[220],"showed":[221],"strong":[223],"dependency":[224],"age":[226,235],"fattening":[228],"between":[229],"10":[232],"weeks":[233],"both":[237],"genotypes.(ABSTRACT":[238],"TRUNCATED":[239],"AT":[240],"250":[241],"WORDS)":[242]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}